Recombinant fibroblast interferon and immune interferon for treating chronic hepatitis B virus infection: patients' tolerance and the effect on viral markers.
D000328:Adult; D002908:Chronic Disease; D004259:DNA-Directed DNA Polymerase / Q000097:blood*; D004359:Drug Therapy, Combination; D006509:Hepatitis B / Q000382:microbiology / Q000628:therapy*; D006515:Hepatitis B virus / Q000201:enzymology*; D006521:Hepatitis, Chronic / Q000628:therapy; D006716:Homosexuality; D006801:Humans; D007370:Interferon Type I / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D007371:Interferon-gamma / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D011994:Recombinant Proteins
D007370:Interferon Type I; D011994:Recombinant Proteins; D007371:Interferon-gamma; D004259:DNA-Directed DNA Polymerase